“`html

Unlocking the Mystery of Statin Side Effects: New Research Reveals⁢ How Muscle Problems Arise

Statins are a cornerstone of cardiovascular⁢ disease⁤ prevention, substantially reducing the risk of heart attacks and strokes for millions worldwide. However, a significant drawback ⁢of statin therapy is the incidence of muscle-related side effects, ranging from mild soreness to, rarely, severe muscle damage. Recent research from the University of British Columbia, in collaboration with the University of Wisconsin-Madison, has shed light on the ⁤molecular mechanisms behind thes adverse effects, paving the way for the advancement of safer statin medications. University of British Columbia News

How Statins Impact Muscle Cells: The Role of the Ryanodine Receptor

The research, published in nature Communications, focuses on the interaction between statins and ⁤the ryanodine receptor 1 (RyR1), a crucial protein found in muscle cells. Nature ⁣Communications RyR1 regulates calcium flow within muscle cells, controlling ⁤muscle contraction. Calcium is⁢ essential for muscle function,but an uncontrolled release can be toxic.

Using cryo-electron⁣ microscopy – a powerful imaging technique that allows scientists to ⁤visualize proteins at near-atomic resolution – researchers observed that statins bind to RyR1,causing the calcium channel to remain ⁢open longer than it should. This⁣ prolonged opening leads to a continuous leak of calcium into the muscle cell, ultimately causing damage and contributing to muscle pain,⁢ weakness, ⁢and, in rare cases, rhabdomyolysis (muscle breakdown that can lead to kidney failure).

The Unique Statin Binding Mechanism

The study specifically investigated atorvastatin, a commonly prescribed statin.⁤ However, researchers believe the underlying mechanism is likely applicable to other statins within the drug class. ⁢ Their findings revealed a surprising and specific binding pattern:

• Initial Binding: One statin molecule initially binds to the RyR1 channel while it’s ‍closed, preparing it to open.
• Clustering Effect: Two⁢ additional statin‍ molecules then attach,effectively forcing the channel fully open.
• Unusual Clustering: This three-molecule clustering within⁣ a specific pocket of the protein had not been previously observed.

“This is‍ the first time we’ve had a clear picture of how statins activate ‍this channel,” explains Dr. Filip Van Petegem, a professor at UBC’s Life Sciences Institute. University of British Columbia News “It’s a big step forward as it gives us a roadmap for designing statins that don’t interact with muscle tissue.”

Toward Safer Cholesterol-Lowering Drugs

The identification of this specific binding⁣ mechanism offers a clear target for drug development. By modifying the statin molecule ⁣to eliminate the components responsible for interacting with RyR1, researchers aim to create statins that maintain their cholesterol-lowering efficacy while⁢ significantly reducing the risk